<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39319285</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2468-0427</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Infectious Disease Modelling</Title><ISOAbbreviation>Infect Dis Model</ISOAbbreviation></Journal><ArticleTitle>Regional variations in HIV diagnosis in Japan before and during the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>40</StartPage><EndPage>49</EndPage><MedlinePgn>40-49</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idm.2024.08.004</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The number of people undergoing voluntary HIV testing has abruptly decreased since 2020. The geographical heterogeneity of HIV infection and the impact of COVID-19 on the diagnosis of HIV at regional level are important to understand. This study aimed to estimate the HIV incidence by geographical region and understand how the COVID-19 pandemic influenced diagnosis of HIV.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used an extended back-calculation method to reconstruct the epidemiological dynamics of HIV/AIDS by geographical region. We used eight regions: Tokyo, the capital of Japan, Hokkaido plus Tohoku, Kanto plus Koshinetsu (excluding Tokyo), Hokuriku, Tokai, Kinki, Chugoku plus Shikoku, and Kyushu plus Okinawa. Four different epidemiological measurements were evaluated: (i) estimated HIV incidence, (ii) estimated rate of diagnosis, (iii) number of undiagnosed HIV infections, and (iv) proportion of HIV infections that had been diagnosed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The incidence of HIV/AIDS during the COVID-19 pandemic from 2020 to 2022 increased in all regions except Kanto/Koshinetsu (51.3 cases/year), Tokyo (183.9 cases/year), Hokuriku (1.0 cases/year), and Tokai (43.1 cases/year). The proportion of HIV infections that had been diagnosed only exceeded 90% in Tokyo (91.7%, 95% confidence interval (CI): 90.6, 93.3), Kanto/Koshinetsu (91.0%, 95% CI: 87.3, 97.8), and Kinki (92.5%, 95% CI: 90.4, 95.9). The proportion of infections that had been diagnosed was estimated at 83.3% (95% CI: 75.1, 98.7) in Chugoku/Shikoku and 80.5% (95% CI: 73.9, 91.0) in Kyusyu/Okinawa.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In urban regions with major metropolitan cities, including Tokyo, Kinki, and Kanto/Koshinetsu, the number of undiagnosed HIV infections is substantial. However, the proportion of undiagnosed infections was estimated to be smaller than in other regions. The diagnosed proportion was the lowest in Kyusyu/Okinawa (80.5%), followed by Chugoku/Shikoku and Hokkaido/Tohoku. The level of diagnosis in those regional prefectures may have been more influenced and damaged by the COVID-19 pandemic than in urban settings.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishiura</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Graduate School of Medicine, Kyoto University, Yoshidakonoecho, Sakyo-ku, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujiwara</LastName><ForeName>Seiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Graduate School of Medicine, Kyoto University, Yoshidakonoecho, Sakyo-ku, Kyoto, 606-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imamura</LastName><ForeName>Akifumi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirasaka</LastName><ForeName>Takuma</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>NHO Osaka National Hospital, AIDS Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Infect Dis Model</MedlineTA><NlmUniqueID>101692406</NlmUniqueID><ISSNLinking>2468-0427</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIDS</Keyword><Keyword MajorTopicYN="N">Community</Keyword><Keyword MajorTopicYN="N">Geographical variations</Keyword><Keyword MajorTopicYN="N">Heterogeneity</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Statistical estimation</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319285</ArticleId><ArticleId IdType="pmc">PMC11419811</ArticleId><ArticleId IdType="doi">10.1016/j.idm.2024.08.004</ArticleId><ArticleId IdType="pii">S2468-0427(24)00097-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aalen O.O., Farewell V.T., De Angelis D., Day N.E., Gill O.N. A markov model for HIV disease progression including the effect of HIV diagnosis and treatment: Application to AIDS prediction in england and wales. Statistics in Medicine. 1997;16(19):2191–2210. doi: 10.1002/(sici)1097-0258(19971015)16:19&lt;2191::aid-sim645&gt;3.0.co;2-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-0258(19971015)16:19&lt;2191::aid-sim645&gt;3.0.co;2-5</ArticleId><ArticleId IdType="pubmed">9330428</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Prevention Information Network. (n.d.). Annual Report on the Status of HIV/AIDS in Japan. Retrieved August 18, 2023, from https://api-net.jfap.or.jp/status/japan/nenpo.html.</Citation></Reference><Reference><Citation>Boldsen J.L., Jensen J.L., Sogaard J., Sorensen M. On the incubation time distribution and the Danish AIDS data. Journal of the Royal Statistical Society: Series A. 1988;151(1):42–43. doi: 10.2307/2982183.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2982183</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookmeyer R., Gail M.H. Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (London, England) 1986;2(8519):1320–1322. doi: 10.1016/s0140-6736(86)91444-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(86)91444-3</ArticleId><ArticleId IdType="pubmed">2878184</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookmeyer R., Gail M.H. A method for obtaining short-term projections and lower bounds on the size of the AIDS epidemic. Journal of the American Statistical Association. 1988;83(402):301–308. doi: 10.1080/01621459.1988.10478599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1988.10478599</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookmeyer R., Goedert J.J. Censoring in an epidemic with an application to hemophilia-associated AIDS. Biometrics. 1989;45(1):325–335. doi: 10.2307/2532057.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2532057</ArticleId><ArticleId IdType="pubmed">2720058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejima K., Koizumi Y., Yamamoto N., Rosenberg M., Ludema C., Bento A.I., Yoneoka D., Ichikawa S., Mizushima D., Iwami S. HIV testing by public health centers and municipalities and new HIV cases during the COVID-19 pandemic in Japan. Journal of Acquired Immune Deficiency Syndromes. 2021;87(2):e182–e187. doi: 10.1097/QAI.0000000000002660. 1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002660</ArticleId><ArticleId IdType="pmc">PMC8126475</ArticleId><ArticleId IdType="pubmed">33625066</ArticleId></ArticleIdList></Reference><Reference><Citation>Granich R.M., Gilks C.F., Dye C., Williams B.G. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet (London, England) 2009;373(9657):48–57. doi: 10.1016/S0140-6736(08)61697-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)61697-9</ArticleId><ArticleId IdType="pubmed">19038438</ArticleId></ArticleIdList></Reference><Reference><Citation>Granich R., Williams B., Montaner J., Zuniga J.M. 90-90-90 and ending AIDS: Necessary and feasible. Lancet (London, England) 2017;390(10092):341–343. doi: 10.1016/S0140-6736(17)31872-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31872-X</ArticleId><ArticleId IdType="pubmed">28745591</ArticleId></ArticleIdList></Reference><Reference><Citation>Habila M.A., Obeng-Kusi M., Ali M.J., Magaji F.A., Shambe I.H., Daru P.H., Jacobs E.T., Madhivanan P., Sagay A.S., Musa J. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria. BMC Women's Health. 2023;23(1):640. doi: 10.1186/s12905-023-02782-6. 2023 Nov 30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12905-023-02782-6</ArticleId><ArticleId IdType="pmc">PMC10687784</ArticleId><ArticleId IdType="pubmed">38037005</ArticleId></ArticleIdList></Reference><Reference><Citation>Heunis C., Chikobvu P., Muteba M., Kigozi-Male G., Engelbrecht M., Mushori P. Impact of COVID-19 on selected essential public health services - lessons learned from a retrospective record review in the Free State, South Africa. BMC Health Services Research. 2023;23(1):1244. doi: 10.1186/s12913-023-10166-7. 2023 Nov 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-023-10166-7</ArticleId><ArticleId IdType="pmc">PMC10640739</ArticleId><ArticleId IdType="pubmed">37951875</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto A., Taira R., Yokomaku Y., Koibuchi T., Rahman M., Izumi Y., Tadokoro K. The HIV care cascade: Japanese perspectives. PLoS One. 2017;12(3) doi: 10.1371/journal.pone.0174360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174360</ArticleId><ArticleId IdType="pmc">PMC5358866</ArticleId><ArticleId IdType="pubmed">28319197</ArticleId></ArticleIdList></Reference><Reference><Citation>Japanese Association of Public Health Center Directors  Number and trend of public health center establishments. 2023. http://www.phcd.jp/03/HCsuii/ n.d.</Citation></Reference><Reference><Citation>Joves P.J.M., Matulac M.O., Pagcatipunan R.S., Jr. Barriers to antiretroviral medication adherence in people living with HIV (PLHIV) at the time of the COVID-19 pandemic in the Philippines. Travel Medicine and Infectious Disease. 2023;8(10):461. doi: 10.3390/tropicalmed8100461. 2023 Sep. 29.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed8100461</ArticleId><ArticleId IdType="pmc">PMC10610625</ArticleId><ArticleId IdType="pubmed">37888589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimanga D.O., Makory V.N.B., Hassan A.S., Ngari F., Ndisha M.M., Muthoka K.J., Odero L., Omoro G.O., Aoko A., Ng'ang'a L. Impact of the COVID-19 pandemic on routine HIV care and antiretroviral treatment outcomes in Kenya: A nationally representative analysis. PLoS One. 2023;18(11) doi: 10.1371/journal.pone.0291479. 2023 Nov 27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0291479</ArticleId><ArticleId IdType="pmc">PMC10681195</ArticleId><ArticleId IdType="pubmed">38011132</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto S., Nagai M., Tran L.K., Yamaoka K., Nguyen H.D.T., Tanuma J., Pham T.N., Oka S., Van Tran G. Multicenter observational survey on psychosocial and behavioral impacts of COVID-19 in people living with HIV in Northern Vietnam. Scientific Reports. 2023;13(1) doi: 10.1038/s41598-023-47577-9. 2023 Nov 21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47577-9</ArticleId><ArticleId IdType="pmc">PMC10663486</ArticleId><ArticleId IdType="pubmed">37989776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health, Labor and Welfare  Number of public health centers by establishing entity. 2023. https://www.mhlw.go.jp/content/10900000/000765311.pdf n.d.</Citation></Reference><Reference><Citation>Muñoz A., Xu J. Models for the incubation of AIDS and variations according to age and period. Statistics in Medicine. 1996;15(21–22):2459–2473. doi: 10.1002/(sici)1097-0258(19961130)15:22&lt;2459::aid-sim464&gt;3.0.co;2-q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-0258(19961130)15:22&lt;2459::aid-sim464&gt;3.0.co;2-q</ArticleId><ArticleId IdType="pubmed">8931213</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair G., Celum C., Szydlo D., Brown E.R., et al. REACH Protocol Team . The lancet. HIV. Advance online publication; 2023. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among african adolescent girls and young women: A randomised, open-label, crossover trial. S2352-3018(23)00227-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(23)00227-8</ArticleId><ArticleId IdType="pmc">PMC10756058</ArticleId><ArticleId IdType="pubmed">37898146</ArticleId></ArticleIdList></Reference><Reference><Citation>Japan Broadcasting Corporation. Nakamura K. Things to Be cautious about when lifting restrictions and easing self-restraint measures in response to COVID-19. 2021. https://www.nhk.or.jp/kaisetsu-blog/700/456372.html</Citation></Reference><Reference><Citation>Ndawinz J.D., Costagliola D., Supervie V. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: Results for France. AIDS. 2011;25(15):1905–1913. doi: 10.1097/QAD.0b013e32834af619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32834af619</ArticleId><ArticleId IdType="pubmed">21811147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H. Estimating the incidence and diagnosed proportion of HIV infections in Japan: A statistical modeling study. PeerJ. 2019;7 doi: 10.7717/peerj.6275.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.6275</ArticleId><ArticleId IdType="pmc">PMC6338104</ArticleId><ArticleId IdType="pubmed">30671310</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H., Fujiwara S., Imamura A., Shirasaka T. HIV incidence before and during the COVID-19 pandemic in Japan. Mathematical Biosciences and Engineering: MBE. 2024;21(4):4874–4885. doi: 10.3934/mbe.2024215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/mbe.2024215</ArticleId><ArticleId IdType="pubmed">38872518</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoli C., Van de Velde N., Richman B., Allan B., Castellanos E., Young B., Brough G., Eremin A., Corbelli G.M., Mc Britton M., Hardy W.D., de Los Rios P. Undetectable equals untransmittable (U = U): Awareness and associations with health outcomes among people living with HIV in 25 countries. Sexually Transmitted Infections. 2021;97(1):18–26. doi: 10.1136/sextrans-2020-054551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/sextrans-2020-054551</ArticleId><ArticleId IdType="pmc">PMC7841488</ArticleId><ArticleId IdType="pubmed">32732335</ArticleId></ArticleIdList></Reference><Reference><Citation>Penot P., Chateauneuf J., Auperin I., Cordel H., Letembet V.A., Bottero J., Cailhol J. Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France. PLoS One. 2023;18(10) doi: 10.1371/journal.pone.0276038. 2023 Oct 20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276038</ArticleId><ArticleId IdType="pmc">PMC10588853</ArticleId><ArticleId IdType="pubmed">37862300</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano V., Blasco-Fontecilla H., Gallego L., Fernández-Montero J.V., Mendoza C., Barreiro P. Rebound in sexually transmitted infections after the COVID-19 pandemic. AIDS Reviews. 2023;26(3):127–135. doi: 10.24875/AIDSRev.230000. 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.230000</ArticleId><ArticleId IdType="pubmed">37879632</ArticleId></ArticleIdList></Reference><Reference><Citation>The Committee of AIDS Trends, Ministry of Health, Labour and Welfare. HIV/AIDS in Japan. Tokyo, Ministry of Health, Labour and Welfare. https://api-net.jfap.or.jp/status/japan/nenpo.html.</Citation></Reference><Reference><Citation>UNAIDS. An ambitious treatment target to help end the AIDS epidemic. https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf.</Citation></Reference><Reference><Citation>UNAIDS  Undetectable = untransmittable. 2018. https://www.unaids.org/en/resources/presscentre/featurestories/2018/july/undetectable-untransmittable</Citation></Reference><Reference><Citation>Wand H., Wilson D., Yan P., Gonnermann A., McDonald A., Kaldor J., Law M. Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: Results from a modified back-projection method. Journal of the International AIDS Society. 2009;12:19. doi: 10.1186/1758-2652-12-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2652-12-19</ArticleId><ArticleId IdType="pmc">PMC2753624</ArticleId><ArticleId IdType="pubmed">19761622</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>